AAP
AGTC

Ardsley Advisory Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Ardsley Advisory Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,467
Closed -$164K – 200
2015
Q3 		$164K Hold
12,467
– – 0.04% 135
2015
Q2 		$191K Sell
12,467
-2,533
-17% -$48.6K 0.02% 148
2015
Q1 		$300K Buy
+15,000
New +$335K 0.04% 152

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Ardsley Advisory Partners's AGTC Position: Q4 2015 in Review

Ardsley Advisory Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2015, closing a stake of 12,467 shares — an estimated $164K sold.

Ardsley Advisory Partners first reported a position in AGTC in Q1 2015 and held it in 3 quarters. The position peaked at $300K in Q1 2015. 88 funds tracked by Wall St. Rank hold AGTC as of Q4 2015.

  • Ardsley Advisory Partners reported no remaining Applied Genetic Technologies Corporation position as of Q4 2015 after selling out during the quarter.
  • Ardsley Advisory Partners sold 12,467 Applied Genetic Technologies Corporation shares in Q4 2015, an estimated $164K.
  • Ardsley Advisory Partners first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 3 quarters.
  • Ardsley Advisory Partners's Applied Genetic Technologies Corporation position peaked at $300K in Q1 2015.
  • 88 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2015.

Based on Ardsley Advisory Partners's 13F filing for Q4 2015, filed 16 Feb 2016.